Recursion Pharmaceuticals has been trying to rebuild momentum after a steep five year decline in shareholder returns, yet its ...

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Abstract: For hyperspectral image (HSI) classification, it is very important to learn effective features for the discrimination purpose. Meanwhile, the ability to combine spectral and spatial ...

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Abstract: It was recently revealed that using features extracted from pre-trained models can achieve much better performance than using conventional hand-crafted acoustic features for spoofing speech ...

Review the current Recursion Pharmaceuticals Inc Class A (RXRX:XNAS) dividend yield and history to decide if RXRX is the best investment for you.